リンク集 RSS/ATOM 記事
ホーム >>
リンク集 >>
RSS/ATOM 記事 (7089)
ここに表示されている RSS/ATOM 記事を RSS と ATOM で配信しています。
ここに表示されている RSS/ATOM 記事を RSS と ATOM で配信しています。
Apple cancels secretive electric car project in shift to focus on AI
from UK homepage (2024/2/28 6:16:15)
from UK homepage (2024/2/28 6:16:15)
Company ends decade-long research effort as electric vehicle industry loses momentum
Thames Water lobbies for higher bills, dividend payouts and lower fines
from UK homepage (2024/2/28 6:00:01)
from UK homepage (2024/2/28 6:00:01)
Water company seeks to avoid government bailout as officials make contingency plan for its failure dubbed Project Timber
Move comes after pressure from activist groups over transparency and working conditions at ecommerce group
Hunt struggles to find Budget goodies as he faces fiscal ‘headlock’
from UK homepage (2024/2/28 4:49:38)
from UK homepage (2024/2/28 4:49:38)
Deteriorating forecasts pose challenge for UK chancellor as Tory MPs seek tax cuts to improve election prospects
Biden braces for Democrat backlash in Michigan over stance on Gaza
from UK homepage (2024/2/28 4:43:53)
from UK homepage (2024/2/28 4:43:53)
President’s support for Israel’s war on Hamas has angered members of his party in 2024 swing state
White House piles pressure on Republican Speaker over Ukraine aid
from UK homepage (2024/2/28 4:34:41)
from UK homepage (2024/2/28 4:34:41)
Senate leaders from both parties urge Trump-ally Mike Johnson to back more US funding for Kyiv
Government confirms Henry Staunton’s claim about probe into Nick Read but gives no details
McKinsey website touted its advice to Chinese government ministries
from UK homepage (2024/2/28 3:34:44)
from UK homepage (2024/2/28 3:34:44)
Consultancy says marketing claims were ‘inaccurate’ and it has never worked for Beijing
The EU is missing out on trillions of euros of capital for its businesses
Viking Therapeutics shares more than double on ‘statistically significant’ weight-loss trial results
from UK homepage (2024/2/28 2:52:33)
from UK homepage (2024/2/28 2:52:33)
US biotech group’s data suggests dominance of Novo Nordisk and Eli Lilly in the anti-obesity segment could be challenged in a few years
execution time : 0.091 sec